Wyeth Warning Letter Reflects Continued Difficulties With Hormone Manufacturing
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA cites the company for GMP violations involving the oral contraceptive Triphasil-28 and Prempro, which has had a slew of recalls in recent years.